COVID-19 and sickle cell disease in Bahrain.
Int J Infect Dis
; 101: 14-16, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-791252
ABSTRACT
INTRODUCTION:
Coronavirus disease 2019 (COVID-19) is caused by a newly identified strain of the coronavirus family that has been shown to affect the hemoglobin beta chain, the same chain that has sickle cell disease (SCD) mutation. This study was undertaken to see if COVID-19 infection increased disease severity in patients with SCD.METHODS:
Mass screening of the Bahraini population was undertaken between February and April 2020.RESULTS:
A total of 38,092 Bahraini people were tested for COVID-19 during this period; 378 (1%) were SCD patients. Six patients with SCD had COVID-19 (1.6%) three remained asymptomatic, two had mild symptoms and one required oxygen therapy. The SCD patients had a similar average length of stay when compared with non-SCD COVID-19 patients (10.7 days).CONCLUSION:
The infection rate, clinical course and viral clearance seen for the SCD patients with COVID-19 were no different to those without SCD.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
SARS-CoV-2
/
COVID-19
/
Anemia, Sickle Cell
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Country/Region as subject:
Asia
Language:
English
Journal:
Int J Infect Dis
Journal subject:
Communicable Diseases
Year:
2020
Document Type:
Article
Affiliation country:
J.ijid.2020.09.1433
Similar
MEDLINE
...
LILACS
LIS